Our Story

A Mission Fuelled by Loss, Driven by Hope: Why We Need You.

Our story began in July 2020, when a cruel twist of fate stole my sister from us. Colorectal cancer, linked to a gene we apparently share, shattered our world. Grief was a constant companion, but it also ignited a fire within my youngest brother, Pejman. Fuelled by love and a fierce determination to honour her memory, he poured his heart into researching an early detection method for colorectal cancer (CRC).

Pejman's thesis on, "The Link between Human Microbiota and Colorectal Cancer Progression," (read it here) sparked a crucial question: could we use this knowledge to develop a solution for prevention or early-stage CRC detection? Our market research confirmed a critical gap existed – a test that could save countless lives by identifying CRC before it progresses.

This wasn't entirely new territory for us. At that time, we were working together on a project to realise a group of in-vitro diagnostic (IVD) products to be used to identify various bacteria in infectious disease detection. However, we couldn’t afford to initiate an immense project like this on top of what we already had and also the limitations of working as an entrepreneur in Iran were suffocating by the time. We knew this solution, born from tragedy, had the potential to make a global impact and we could see a future where countless lives could be saved. But it demanded cutting-edge resources and a global market that reaching them was beyond our immediate grasp.

That's when I made a difficult yet hopeful decision. I moved to the UK. Here, I could gain experience, build a network, and find passionate individuals and partners who shared our vision. For nearly three years, we have meticulously gathered a determined, enthusiastic and ambitious team of pharmaceutics, biotechnologists, and bioinformatics to realise our mission. I quit my job, and took a leap of faith, like Reid Hoffman's cliff-jumping entrepreneur, though it felt terrifying, the potential to save lives fuelled our descent.

Why We Need a 'Digital Body'

The human gut is incredibly complex! Inside, countless bacteria interact with our food, our immune system, and even our organs. This generates a massive amount of data that no human could ever fully analyse. That's where our computer model comes in. It uses artificial intelligence to find hidden patterns within this data, just like a super-powered detective. These patterns – combined with other research – allow us not only to Identify changes in the gut bacteria that could act as early warning signs for colorectal cancer but also could be used to predict situations like:

• IBS Relief: Find out what triggers IBS flare-ups for an individual – certain foods, medications? Predict which treatments might help them manage symptoms without trial and error.

• Personalised Health Plans for Life: Build customised nutrition plans based on someone's unique gut microbiome, ensuring long-term gut health. This goes way beyond generic healthy eating, targeting conditions like IBS or supporting those at risk for CRC.

• Discoveries on the Horizon: Test new medications, probiotics, or even food ingredients within the model. Those showing promise can be fast-tracked for real-world studies.

Think of our platform as a digital replica of the human body, especially focused on the gut. It's a complex computer model that shows how the digestive system, immune system, and gut microbiome interact with each other as well as whole body systems. Could your diet today be protecting you from colorectal cancer, or putting you at risk? Our model can help find out. With this virtual model, we can run tests to predict how specific things will affect a person's health – both now and in the future (learn more our technology here).

Why This is Groundbreaking

Our model empowers prevention. Instead of reacting to health problems, it reveals how today's dietary choices could impact gut health years down the line and even optimise the timing of when specific foods or probiotics are most beneficial. This is revolutionary for people with IBS or at risk for colorectal cancer!

What Can We Do With It?

• Design Better Medicines: We can test how a new drug might affect a patient – will it work well, are there side effects, how does the person's gut bacteria impact the drug? This leads to safer and more personalised treatment plans.

• Improve Diet and Nutrition: Predict how different foods, supplements, or even whole diets affect a person's metabolism. This helps create individualised plans for managing health conditions or even preventing illness entirely.

• Speed Up Discoveries: Quickly screen potential new drug compounds or ingredients within the model. Those that look promising get fast-tracked for real-world testing, saving time and resources.

Why It Matters

Currently, medicine is often a bit of guesswork, even with doctors' expertise. Our platform helps remove that guesswork. It's like having a crystal ball to see how a treatment or dietary change will affect a person before they even try it!

Partner with Us to Unlock Breakthroughs in Gut Health

Our powerful computational platform isn't just for our own research – it's a tool to accelerate discoveries across the field. We invite researchers, health innovators, and companies to partner with us and harness the insights our model can reveal:

• Researchers:

  • Have you collected valuable gut microbiome datasets but lack the tools for in-depth analysis? Our platform can uncover hidden patterns, linking them to disease risk, treatment responses, or dietary influences.

  • Struggling to translate findings from in vitro or animal models to humans? Our model helps bridge that gap, predicting how your discoveries could play out in real-world patients.

• Health Innovators (Food, Supplements, Pharmaceuticals):

  • Validate your product's efficacy on specific populations. We can analyse if its impact is influenced by gut bacteria, improving your targeting and marketing claims.

  • Accelerate R&D with early-stage predictions. Screen new compounds or potential prebiotics within our model before costly trials, improving your success rate.

The Win-Win: Your Data + Our Platform = Accelerated Progress

This collaboration isn't one-sided. Your datasets play a crucial role in refining and validating our platform. As more diverse data is integrated, our model becomes even more powerful and predictive.

Together, we can:

• Advance our understanding of the gut microbiome's role in health and disease with actionable insights.

• Develop more effective, personalised interventions tailored to those who need them most.

• Pioneer new frontiers in gut health innovation, ultimately improving lives.

Let's Start a Conversation: Contact us to discuss how our platform can power your research project or product development.

Join us, and together, let's turn a tragedy into a triumph. Let's save lives.

We're searching for brilliant minds – researchers, investors, dreamers – who share our commitment to making a difference. We need your expertise, your passion, and your unwavering belief in the power of science to rewrite a narrative dominated by loss.

Follow us to join our mission:

• Investors: Looking to support a cutting-edge company with the potential to revolutionise colorectal cancer detection and save lives? Discover the science and the personal story behind our mission.

• Medicine Discovery, Food, & Supplement Innovators: Ready to elevate your products with microbiome-driven insights? Explore how our platform validates efficacy, accelerates development, and strengthens your claims.

• Researchers, Healthcare Professionals, Dietitians & individuals: Passionate about personalised medicine and gut health? Learn how our model empowers data-driven treatment decisions and preventative dietary guidance.

Amplify our reach. Share our story with your network and help us realise a future where colorectal cancer is detected early, and gut health is optimised for better lives.

Together, we can turn the tide. Are you ready to jump?

Follow us